DRKS00015231招募中3 期
Prostate bed irradiation with alternative radio-oncological approaches - PAROS
niversitätsklinikum HeidelbergAbteilung RadioOnkologie und Strahlentherapie0 个研究点目标入组 897 人开始时间: 2018年9月27日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 897
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •histologically confirmed prostate cancer with classification according to the Gleason score and recent PSA-value
- •- Indication for the irradiation of the prostate bed (adjuvant / salvage) after prostatectomy
- •- Karnofsky index = 70%
- •- Age = 18 years
- •- Patient information and written consent
- •- Ability of the patient to consent
排除标准
- •- antihormonal therapy
- •- lymphoid metastasis
- •- Stage IV (distant metastases)
- •- previous radiotherapy in the pelvis
- •- hip total endoprosthesis
- •- Simultaneous participation in another clinical trial that could influence the results of one of the studies
研究者
相似试验
招募中
3 期
Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA Trial)2024-520093-34-00Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia310
已完成
2 期
A trial of prostate radiotherapy in conjunction with carbogen and nicotinamideMalignant neoplasm of prostateCancerProstate cancerISRCTN08912168East and North Hertfordshire Hospitals NHS Trust (UK)50
进行中（未招募）
1 期
Prostate Radiotherapy with Oxygen EnhancementMedDRA version: 14.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate CancerEUCTR2010-021886-63-GBEast and North Hertfordshire NHS Trust50
进行中（未招募）
1 期
Artificial Intelligence driven personalisation of radiotherapy and concomitant androgen deprivation therapy for prostate cancer patientsMedDRA version: 20.0Level: PTClassification code: 10060862Term: Prostate cancer Class: 100000004864Prostate cancerCTIS2024-510707-11-00inac-Pet Scan Opco Limited30
招募中
3 期
Prostate Radiotherapy In high risk and node positive disease comparing Moderate & Extreme hypofractionation.CTRI/2018/05/014054Tata Memorial Centre Department of Atomic Energy Clinical Trial Centre